New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders o
NEWTOWN, Pa. , Nov. 10, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Agilon Health, Inc. ("Agilon" or "the Company") (NYSE:
AGL Energy said on Monday it has sold 19.9% of its 20% stake in Tilt Renewables, a clean energy developer, for A$750 million ($487.35 million) to a group led by Queensland Investment Corp (QIC) and Au
New York, New York--(Newsfile Corp. - November 9, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of
NEW YORK, Nov. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of agilon health, in
New York, New York--(Newsfile Corp. - November 7, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (the “Company”) (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that the
NEW YORK , Nov. 7, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, in
MIAMI, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Shamis & Gentile, P.A. is investigating whether certain directors and officers of agilon health, inc.
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of agilon health, in
agilon health, inc. ( AGL ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Evan Smith - Senior Vice President of Investor Relations Ronald Williams - Executive Chairman Jeffre
The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Agilon Health (AGL) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.29 per share a year ago.
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarte
New York, New York--(Newsfile Corp. - November 4, 2025) - WHY: Rosen Law Firm, a global investor rights law firm,
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE